Remoxipride (Roxiam) is an atypical antipsychotic (although according to some sources it is a typical antipsychotic) which was previously used in Europe for the treatment of schizophrenia and acute mania but was withdrawn due to toxicity concerns (incidence of aplastic anemia in 1/10,000 patients). It was initially launched by AstraZeneca in 1990 ...
Found on
http://en.wikipedia.org/wiki/Remoxipride
<chemical> An antipsychotic agent that is specific for dopamine d2 receptors. It has been shown to be effective in the treatment of schizophrenia. ... Pharmacological action: antipsychotic agents, dopamine antagonists. ... Chemical name: Benzamide, 3-bromo-N-((1-ethyl-2-pyrrolidinyl)methyl)-2,6-dimethoxy-, (S)- ... (12 Dec 1998) ...
Found on
http://www.encyclo.co.uk/local/20973
No exact match found.
